by Daniel X. Thomas
Brief outline of the case
The OD rejected the opposition.
The opponent appealed.
By decision T 760/17, the board decided not to admit a series of late-filed AR under Art 13(2) RPBA20. It also decided to revoke the patent for lack of IS of claim 1 as granted and of all AR I-IX which were timely filed.
by Daniel X. Thomas
The patent relates to an apparatus and method for providing metered amounts of ingredients to a nutritional composition for use in administration to an infant.
Brief outline of the case
The OD held that the MR before it lacked clarity and revoked the patent.
The proprietor appealed the decision.
The update of our EPC.App reference book to legal status of 1st April 2023 is completed. Key changes since the last update in November were the new EPO Guidelines as of March 2023, G 2/21 on plausibility, amendments to Rules 46, 49, 50, 57, 82 on format requirements of application documents as well as to Rule 65 on the transmittal of the search report, the increase of EPO fees, and the upcoming UPCA entry into force.
In the self-editable online version of our EPC commentary, all changes of the update are rolled-out automatically, while personal user annotations from before the update are retained. They can be exported into a customized printable PDF offline version, which may further be ordered as colored paperback via the integrated print-on-demand service. As usual, we also released this 10th edition as standalone softcover books in English or German with same content.
by Daniel X. Thomas
Generally speaking the application relates to injection pens to be used by diabetic patients without requiring the help of medically qualified persons.
Claims 1-11 as granted relate to an assembly for drug delivery and claim 12 as granted relates to a drug delivery device comprising the assembly of at least one of the previous claims.
